METHOD OF QUANTITATIVE DETERMINATION OF ANTIGEN PROTEIN AND QUANTITATIVE DETERMINATION KIT THEREFOR
    2.
    发明申请
    METHOD OF QUANTITATIVE DETERMINATION OF ANTIGEN PROTEIN AND QUANTITATIVE DETERMINATION KIT THEREFOR 审中-公开
    定量测定抗原蛋白质和定量测定试剂盒的方法

    公开(公告)号:US20100015643A1

    公开(公告)日:2010-01-21

    申请号:US12301535

    申请日:2007-05-21

    IPC分类号: G01N33/567

    摘要: There is provided a method of quantitative determination using a flow cytometer, with which quantitative determination of cell surface protein can be effected more accurately than with current methods. The inventors have achieved the present invention by providing a method of quantitative determination of sites, per cell of a test sample, at which an antibody is bound to an antigen protein (sites/cell), characterized by preparing a calibration curve on the basis of fluorescent intensities obtained through measuring with a flow cytometer the amount of labeled antibodies against antigen protein which are bound to two or more groups of beads carrying known and different amounts of the antigen protein, and numeric values of the known amounts of the antigen protein, and further by measuring, with the flow cytometer, labeled antibodies against antigen protein after they have been reacted with test cells derived from a blood sample of a test subject, whereby digitalization is effected through comparison and conversion between the calibration curve and a fluorescence intensity obtained.

    摘要翻译: 提供了一种使用流式细胞仪进行定量测定的方法,可以比目前的方法更准确地进行细胞表面蛋白的定量测定。 发明人通过提供定量测定抗体与抗原蛋白(位点/细胞)结合的测试样品的每个细胞的位点的方法来实现本发明,其特征在于基于以下方式制备校准曲线 通过用流式细胞仪测量获得的荧光强度,结合到携带已知和不同量的抗原蛋白的两个或更多个珠粒组的抗原蛋白的标记抗体的量,以及已知量的抗原蛋白的数值,以及 进一步通过用流式细胞仪测量抗原蛋白的抗体,在与测试受试者的血液样本的测试细胞反应之后,通过比较和转换校正曲线和获得的荧光强度来进行数字化。

    Method of identifying properties of substance with respect to human prostaglandin D2 receptors
    3.
    发明授权
    Method of identifying properties of substance with respect to human prostaglandin D2 receptors 有权
    识别物质相对于人类前列腺素D2受体的性质的方法

    公开(公告)号:US06884593B1

    公开(公告)日:2005-04-26

    申请号:US10069148

    申请日:2000-08-22

    CPC分类号: G01N33/88 G01N2500/04

    摘要: An object of the present invention is to provide a method of identifying a substance which acts on a newly found second human prostaglandin D2 receptor subtype that differs from the DP receptor, and is useful for treating or preventing various diseases. In order to attain the object, the present invention provides a method of identifying properties of a test substance with respect to a human prostaglandin D receptor, by establishing correlation between the effect of a test substance on human CRTH2 with the effect of the test substance on the human prostaglandin D receptor.

    摘要翻译: 本发明的目的是提供一种鉴定作用于新发现的与DP受体不同的第二人前列腺素D 2受体亚型的物质的方法,并且可用于治疗或预防各种 疾病 为了达到上述目的,本发明提供了一种鉴定被测物质相对于人前列腺素D受体的性质的方法,其特征在于,测试物质对人CRTH2的作用与受检物质对 人类前列腺素D受体。

    Induced pluripotent stem cells
    4.
    发明授权
    Induced pluripotent stem cells 有权
    诱导多能干细胞

    公开(公告)号:US09580689B2

    公开(公告)日:2017-02-28

    申请号:US13811572

    申请日:2011-07-22

    摘要: Described herein is a major breakthrough in nuclear reprogramming and induced pluripotent stem cell (iPSC) technology. Fusion of the powerful transcription activation domain (TAD) of MyoD to the Oct4 protein makes iPSCs generation faster, more efficient, purer, safer and feeder-free. Also, disclosed herein is the first report of the use of a TAD fused to a transcription factor as a method for making iPSCs. By combining transcription factors and TADs, this approach to nuclear reprogramming can have a range of applications from inducing pluriopotency to inducing transdifferentiation without transitioning through iPSCs.

    摘要翻译: 这里描述的是核重新编程和诱导多能干细胞(iPSC)技术的重大突破。 将MyoD强大的转录激活结构域(TAD)融合到Oct4蛋白质中,使得iPSC生成更快,更有效,更纯净,更安全,更无饲料。 此外,本文公开的是使用与转录因子融合的TAD作为制备iPSC的方法的第一个报告。 通过组合转录因子和TAD,这种核重新编程方法可以具有诱导多能性诱导转分化而不通过iPSC过渡的应用范围。

    INDUCED PLURIPOTENT STEM CELLS
    5.
    发明申请
    INDUCED PLURIPOTENT STEM CELLS 有权
    诱导的大脑干细胞

    公开(公告)号:US20130195812A1

    公开(公告)日:2013-08-01

    申请号:US13811572

    申请日:2011-07-22

    IPC分类号: C12N5/071

    摘要: Described herein is a major breakthrough in nuclear reprogramming and induced pluripotent stem cell (iPSC) technology. Fusion of the powerful transcription activation domain (TAD) of MyoD to the Oct4 protein makes iPSCs generation faster, more efficient, purer, safer and feeder-free. Also, disclosed herein is the first report of the use of a TAD fused to a transcription factor as a method for making iPSCs. By combining transcription factors and TADs, this approach to nuclear reprogramming can have a range of applications from inducing pluriopotency to inducing transdifferentiation without transitioning through iPSCs.

    摘要翻译: 这里描述的是核重新编程和诱导多能干细胞(iPSC)技术的重大突破。 将MyoD强大的转录激活结构域(TAD)融合到Oct4蛋白质中,使得iPSC生成更快,更有效,更纯净,更安全,更无饲料。 此外,本文公开的是使用与转录因子融合的TAD作为制备iPSC的方法的第一个报告。 通过组合转录因子和TAD,这种核重新编程方法可以具有诱导多能性诱导转分化而不通过iPSC过渡的应用范围。

    MRI CONTRAST MEDIUM CONTAINING LIPOSOMES
    6.
    发明申请
    MRI CONTRAST MEDIUM CONTAINING LIPOSOMES 审中-公开
    MRI对比中药含有脂质体

    公开(公告)号:US20090130022A1

    公开(公告)日:2009-05-21

    申请号:US11916391

    申请日:2006-06-06

    IPC分类号: A61B5/055 A61K9/127

    CPC分类号: A61K49/1812

    摘要: A liposome containing a phosphatidylcholine and a phosphatidylserine in combination as membrane components at a phosphatidylcholine:phosphatidylserine molar ratio of 3:1 to 1:2, and said liposome containing superparamagnetic particles having a mean particle size not less than 1 nm and not more than 50 nm. A means for selectively accumulating an MRI contrast medium in a lesion of a vascular disease caused by abnormal proliferation of vascular smooth muscle cells such as arteriosclerosis and restenosis after PTCA is provided.

    摘要翻译: 含有磷脂酰胆碱和磷脂酰丝氨酸的磷脂酰丝氨酸组合为磷脂酰胆碱的膜组分:磷脂酰丝氨酸摩尔比为3:1至1:2,所述脂质体含有平均粒度不小于1nm且不大于50的超顺磁性颗粒 nm。 用于选择性地累积由血管平滑肌细胞的异常增殖引起的血管疾病的病变中的MRI造影剂的手段,所述血管病变由PTCA提供之后的动脉硬化和再狭窄引起。

    Magnetic Composite Body, Production Method Thereof, Method for Removing Substance with Mannose on Its Surface, and Method for Concentrating Substance with Mannose on Its Surface
    8.
    发明申请
    Magnetic Composite Body, Production Method Thereof, Method for Removing Substance with Mannose on Its Surface, and Method for Concentrating Substance with Mannose on Its Surface 有权
    磁性复合体及其制造方法,其表面用甘露糖去除物质的方法及其表面上用甘露糖浓缩物质的方法

    公开(公告)号:US20080156736A1

    公开(公告)日:2008-07-03

    申请号:US11883742

    申请日:2006-02-08

    IPC分类号: B03C1/02 H01F1/42

    CPC分类号: B03C1/01 B82Y25/00 H01F1/0054

    摘要: A magnetic composite body comprising magnetic nanoparticles having a number average particle diameter of 1 to 50 nm and having a compound represented by formula (I) fixed on their surfaces, and a method comprising bringing the magnetic composite body into contact with a test piece followed by magnetic separation: R1O—(CH(R2)CH2O)n-L-X   Formula (I) wherein R1 represents a hydrogen atom, an alkyl or alkenyl group having a carbon chain length of 1 to 20, or a substituted or unsubstituted, aryl or heterocyclic group; R2 represents a hydrogen atom or a methyl group; L may be present or not present, and, when L is present, L represents an alkylene or alkenylene group having a carbon chain length of 1 to 10 which may have a branched chain or a substituent; X represents a hydrogen atom, a carboxylic acid group, a phosphoric acid group, or a sulfonic acid group; and n represents an integer of 1 to 10

    摘要翻译: 一种磁性复合体,其包含数均粒径为1〜50nm的磁性纳米颗粒,并且具有固定在其表面上的式(I)表示的化合物,以及包括使磁性复合体与试验片接触的方法, 磁分离:<?in-line-formula description =“In-line Formulas”end =“lead”?> R O-(CH(R 2)2 CH 式(I)<?in-line-formula description =“In-line formula”end =“tail”?>其中R 1 表示氢原子,碳链长度为1-20的烷基或烯基,或取代或未取代的芳基或杂环基; R 2表示氢原子或甲基; L可以存在或不存在,并且当存在L时,L表示碳链长度为1至10的亚烷基或亚烯基,其可以具有支链或取代基; X表示氢原子,羧酸基,磷酸基或磺酸基; n表示1〜10的整数

    Doped-type metal sulfide phosphor nanoparticle, dispersion thereof, and method for producing the same
    10.
    发明申请
    Doped-type metal sulfide phosphor nanoparticle, dispersion thereof, and method for producing the same 失效
    掺杂型金属硫化物荧光体纳米颗粒及其分散体及其制造方法

    公开(公告)号:US20070125985A1

    公开(公告)日:2007-06-07

    申请号:US11647368

    申请日:2006-12-29

    IPC分类号: C09K11/54 C09K11/56

    摘要: A doped-type metal sulfide phosphor nanoparticle dispersion, comprising a doped-type metal sulfide phosphor nanoparticle dispersed in water and/or a hydrophilic solvent, wherein the doped-type metal sulfide phosphor nanoparticle comprises a surface that is modified with a surface modifier, the surface modifier being a compound represented by formula [I]: HS-L-W   Formula [I] wherein L represents a divalent linking group; and W represents COOM or NH2, in which M represents a hydrogen atom, an alkali metal atom, or NX4, in which X represents a hydrogen atom or an alkyl group.

    摘要翻译: 掺杂型金属硫化物荧光体纳米颗粒分散体,其包含分散在水中的掺杂型金属硫化物荧光体纳米颗粒和/或亲水性溶剂,其中所述掺杂型金属硫化物荧光体纳米颗粒包括用表面改性剂改性的表面, 表面改性剂是由式[I]表示的化合物:<?in-line-formula description =“In-line Formulas”end =“lead”?> HS-LW Formula [I] <?in-line-formula description = “In-line Formulas”end =“tail”?>其中L表示二价连接基团; W表示COOM或NH 2,其中M表示氢原子,碱金属原子或NX 4,其中X表示氢原子或烷基 。